Detalles de la búsqueda
1.
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.
Int J Cancer
; 151(10): 1791-1803, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695283
2.
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors: A single-center experience.
Int J Cancer
; 148(1): 170-177, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856727
3.
Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Anticancer Res
; 38(6): 3627-3634, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848719
4.
Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
Anticancer Res
; 37(9): 5241-5248, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870960
5.
Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.
J Clin Oncol
; 23(4): 751-8, 2005 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613698
6.
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study.
Gynecol Oncol
; 85(3): 445-50, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12051872
Resultados
1 -
6
de 6
1
Próxima >
>>